Lung Cancer
Conditions
Brief summary
The goal of this clinical trial is to evaluate raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer in visible lesions in the airway. The main question it aims to answer are: the diagnostic efficacy raman spectroscopic analysis of bronchoscopic biopsy for diagnosing lung cancer. The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Interventions
DIAGNOSTIC_TESTRaman spectrum
The bronchoscopic biopsy sample of patients with visible lesions in the airway would undergo raman spectrum analysis.
Sponsors
China-Japan Friendship Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Patients who plan to undergo bronchoscopic biopsy or EBUS-TBNA * Visible intratracheal lesions under bronchoscope * Non-visible lesions suspected of lung cancer
Exclusion criteria
* The patient could not tolerate further examination aimed at clarifying the cause of the disease or refused to accept further examination aimed at clarifying the cause of the disease due to poor general condition, serious organ dysfunction, etc * The patient has no definite diagnosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To establish the sensitivities and specificities of Raman spectroscopic analysis of bronchoscopic biopsy for lung cancer. | 7 days after the biopsy | The diagnosis would be confirmed according to the pathological results. |
Contacts
Primary ContactMingming Deng, MD
Outcome results
None listed